Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Tech & Dev
上一篇:Brooks... delttes tuoyal daor wen revo l
下一篇:Sale... tsiser ot drah tub - seitneveS